ARCHIVES

Mace Rothenberg Leaves Vanderbilt For Pfizer Oncology.

This article is from The Cancer Letter archive.

Vol. 34 No. 42 | November 14, 2008

Download PDF Visit The Full Archive

Related Articles

Guideline Adherence Improves Early Breast Cancer Survival

August 27, 2004

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 5, 1974

CCRAC Calls for New Comp Center, Community Hospital Core Grants For Control Development

August 24, 1979

Four UICC Programs Available For International Research

July 10, 1981

Hybridoma Cell Lines Available from NCI

September 3, 1982

In Brief: Ross Retires From Bristol-Myers, Forms Own Consulting Service; Obey Wins Key Post

April 1, 1994